Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TKPHF) Non-Current Deferred Tax Liability (2017 - 2025)

Historic Non-Current Deferred Tax Liability for Takeda Pharmaceutical (TKPHF) over the last 9 years, with Q4 2025 value amounting to $203.2 million.

  • Takeda Pharmaceutical's Non-Current Deferred Tax Liability fell 1797.97% to $203.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $203.2 million, marking a year-over-year decrease of 1797.97%. This contributed to the annual value of $230.8 million for FY2025, which is 7074.9% down from last year.
  • Per Takeda Pharmaceutical's latest filing, its Non-Current Deferred Tax Liability stood at $203.2 million for Q4 2025, which was down 1797.97% from $224.2 million recorded in Q3 2025.
  • Takeda Pharmaceutical's 5-year Non-Current Deferred Tax Liability high stood at $5.1 billion for Q1 2021, and its period low was $203.2 million during Q4 2025.
  • Moreover, its 5-year median value for Non-Current Deferred Tax Liability was $1.8 billion (2023), whereas its average is $2.1 billion.
  • In the last 5 years, Takeda Pharmaceutical's Non-Current Deferred Tax Liability plummeted by 1084.57% in 2021 and then tumbled by 8187.02% in 2024.
  • Over the past 5 years, Takeda Pharmaceutical's Non-Current Deferred Tax Liability (Quarter) stood at $4.9 billion in 2021, then tumbled by 44.02% to $2.8 billion in 2022, then plummeted by 67.29% to $900.0 million in 2023, then tumbled by 72.47% to $247.8 million in 2024, then decreased by 17.98% to $203.2 million in 2025.
  • Its Non-Current Deferred Tax Liability was $203.2 million in Q4 2025, compared to $224.2 million in Q3 2025 and $231.6 million in Q2 2025.